You are using an outdated browser. Please upgrade your browser to improve your experience.

Parkinson disease

Disease Summary
Associated Targets (247)
Tbio

128

Tclin

59

Tchem

53

Tdark

7


Explore Associated Targets
Mondo Description A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.
Uniprot Description A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features.
Disease Ontology Description A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions.
Mondo Term and Equivalent IDs
MONDO:0005180:  Parkinson disease
COHD:381270: 
EFO:0002508: 
ICD9:332.0: 
MESH:D010300: 
NCIT:C26845: 
OMIMPS:168600: 
SCTID:49049000: 
UMLS:C0030567: 
GWAS Targets (0)
No GWAS traits found
Target Novelty (Tin-x)